Plain-English translation of NCT06972771 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new imaging dye called TTP-ICG that glows under special infrared light to help doctors identify bladder cancer in tissue samples. After your bladder surgery, the tissue removed will be treated with this dye and photographed using a specialized imaging system to see if it can clearly highlight cancer cells and help pathologists make more accurate diagnoses.
Current methods of identifying bladder cancer in tissue samples rely on traditional staining techniques that can sometimes miss small areas of cancer. This new fluorescent dye and imaging system could help doctors spot cancer more accurately and completely, potentially improving treatment outcomes.
You likely qualify if…
You likely don't qualify if…
You would first undergo your planned bladder surgery as normal. After the surgery, the tissue removed from your bladder would be treated with the fluorescent dye in the laboratory—this happens after your surgery is complete and does not involve any additional procedures for you. The dye-treated tissue would then be imaged using a special camera, and the results would be compared with standard pathology findings to see how well the new imaging method works.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China